IA
ATRS

IndexIQ Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

IndexIQ Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$413K Buy
+100,734
New +$365K 0.01% 505
2021
Q1 		– Sell
-88,748
Closed -$354K – 1368
2020
Q4 		$354K Buy
88,748
+9,163
+12% +$29.6K 0.01% 557
2020
Q3 		$215K Buy
79,585
+4,317
+6% +$11.9K 0.01% 588
2020
Q2 		$207K Buy
+75,268
New +$210K 0.01% 542

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

IndexIQ Advisors's ATRS Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Antares Pharma, Inc. (ATRS) in Q1 2022: 100,734 shares worth $413K. The stake represents 0.01% of the portfolio and ranks #505 among its holdings. This is a return to the name: IndexIQ Advisors previously reported a position in ATRS as recently as Q4 2020.

IndexIQ Advisors first reported a position in ATRS in Q2 2020 and has held it in 4 quarters since. 177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

  • IndexIQ Advisors held 100,734 shares of Antares Pharma, Inc. worth $413K as of Q1 2022.
  • Antares Pharma, Inc. was a new IndexIQ Advisors position in Q1 2022.
  • Antares Pharma, Inc. made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #505 holding.
  • IndexIQ Advisors first reported a position in Antares Pharma, Inc. in Q2 2020 and has held it in 4 quarters since.
  • 177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.